Udaya S Tantry - JoVE Visualize

Showing results (141-150 of 227) with videos related to

Pageof 23

Sort By:

Clinical Pharmacokinetics|April 21, 2012

Pharmacokinetics and pharmacodynamics of ticagrelor in patients with stable coronary artery disease: results from the ONSET-OFFSET and RESPOND studiesSteen E Husted, Robert F Storey, Kevin Bliden, et al.

Journal of Thrombosis and Thrombolysis|January 18, 2022

Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomesAbira Usman, Kevin P Bliden, Alastair Cho, et al.

Korean Circulation Journal|March 3, 2021

Ethnic Difference of Thrombogenicity in Patients with Cardiovascular Disease: a Pandora Box to Explain Prognostic DifferencesHyun Kuk Kim, Udaya S Tantry, Hyun Woong Park, et al.

Journal of Thrombosis and Thrombolysis|January 24, 2019

"Blueprinting" thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute strokeKevin P Bliden, Gabe Raviv, Udaya S Tantry, et al.

International Journal of Cardiology|August 4, 2022

Sex-related differences in clinical outcomes among patients with myocardial infarction with nonobstructive coronary artery disease: A systematic review and meta-analysisRahul Chaudhary, Michael Bashline, Enrico M Novelli, et al.

Platelets|January 3, 2024

Utility of VerifyNow to assess the immediate pharmacodynamic response of chewed and swallowed aspirin: comparison with aggregometryKevin P Bliden, Parshotam Kundan, Danielle Kraft, et al.

Journal of Thrombosis and Thrombolysis|March 14, 2024

Development of a routine bedside CYP2C19 genotype assessment program for antiplatelet therapy guidance in a community hospital catheterization laboratoryPaul A Gurbel, Kevin Bliden, Matthew Sherwood, et al.

Journal of the American College of Cardiology|November 16, 2005

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING StudyPaul A Gurbel, Kevin P Bliden, Kirk Guyer, et al.

The Annals of Thoracic Surgery|July 6, 2016

Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?Elisabeth Mahla, Florian Prueller, Sylvia Farzi, et al.

Open Forum Infectious Diseases|July 12, 2021

First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19Udaya S Tantry, Kevin P Bliden, Alastair Cho, et al.

Pageof 23

Showing results (141-150 of 227) with videos related to

Sort By:

Pageof 23

Clinical Pharmacokinetics|April 21, 2012

Pharmacokinetics and pharmacodynamics of ticagrelor in patients with stable coronary artery disease: results from the ONSET-OFFSET and RESPOND studiesSteen E Husted, Robert F Storey, Kevin Bliden, et al.

Journal of Thrombosis and Thrombolysis|January 18, 2022

Metformin use in patients hospitalized with COVID-19: lower inflammation, oxidative stress, and thrombotic risk markers and better clinical outcomesAbira Usman, Kevin P Bliden, Alastair Cho, et al.

Korean Circulation Journal|March 3, 2021

Ethnic Difference of Thrombogenicity in Patients with Cardiovascular Disease: a Pandora Box to Explain Prognostic DifferencesHyun Kuk Kim, Udaya S Tantry, Hyun Woong Park, et al.

Journal of Thrombosis and Thrombolysis|January 24, 2019

"Blueprinting" thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute strokeKevin P Bliden, Gabe Raviv, Udaya S Tantry, et al.

International Journal of Cardiology|August 4, 2022

Sex-related differences in clinical outcomes among patients with myocardial infarction with nonobstructive coronary artery disease: A systematic review and meta-analysisRahul Chaudhary, Michael Bashline, Enrico M Novelli, et al.

Platelets|January 3, 2024

Utility of VerifyNow to assess the immediate pharmacodynamic response of chewed and swallowed aspirin: comparison with aggregometryKevin P Bliden, Parshotam Kundan, Danielle Kraft, et al.

Journal of Thrombosis and Thrombolysis|March 14, 2024

Development of a routine bedside CYP2C19 genotype assessment program for antiplatelet therapy guidance in a community hospital catheterization laboratoryPaul A Gurbel, Kevin Bliden, Matthew Sherwood, et al.

Journal of the American College of Cardiology|November 16, 2005

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING StudyPaul A Gurbel, Kevin P Bliden, Kirk Guyer, et al.

The Annals of Thoracic Surgery|July 6, 2016

Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy?Elisabeth Mahla, Florian Prueller, Sylvia Farzi, et al.

Open Forum Infectious Diseases|July 12, 2021

First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19Udaya S Tantry, Kevin P Bliden, Alastair Cho, et al.

Pageof 23